细胞质表达p16与乳腺癌相关:它不是一个人工物
Sudipta Naskar1, Nadeem Tanveer1, Sonal Sharma1
1Department of Pathology, University College of Medical Sciences & GTB Hospital, Delhi, India.
Iranian journal of pathology
|August 9, 2024
概括
在乳腺组织中,p16蛋白显示出明显的核和细胞质表达模式. 细胞质p16在乳腺癌中普遍存在,但在纤维腺瘤中不存在,而核p16与乳腺癌分子亚型相关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- p16蛋白在核和细胞质两部分都表现出不同的作用.
- 虽然核p16以细胞循环调节而闻名,但细胞质局部化,最初被认为是一种工件,现在被认为具有生物学意义.
- 了解这些位置的p16的差异表达对于乳腺瘤分析至关重要.
研究的目的:
- 为了研究核和细胞质位置的p16蛋白的免疫表达.
- 分析p16表达在纤维腺瘤,侵袭性乳腺癌和乳腺瘤的上皮和脑膜区.
主要方法:
- 免疫组织化学被用来评估p16表达.
- 这项研究分析了107个乳腺组织样本:51种侵袭性乳腺癌,51种纤维腺瘤,4种良性乳腺瘤和1种局部叶状癌.
- 评估了p16定位在上皮细胞和树皮细胞内的核和细胞质区.
主要成果:
- 在侵袭性乳腺癌 (27/51例) 中经常观察到细胞质p16表达,但在纤维腺瘤中没有.
- 在纤维腺瘤 (23/51例) 和侵入性癌瘤 (31/51例) 中观察到核p16表达.
- 在中度至强度的核p16免疫表达和乳腺癌的特定分子亚型之间发现了统计学上显著的相关性.
结论:
- 细胞质p16免疫表达是乳腺癌的特征,在纤维腺瘤中不存在.
- 核p16表达与侵袭性乳腺癌的分子亚型有显著的关联.
- 这些发现突出了p16局部化在乳腺病理学中的差异性作用和诊断潜力.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K